Mercè de Frias

Proud to be part of this! Being a women in science rocks :)

2022 Novel Large Molecule Drug Approvals There were 17 novel large molecule drugs approved by the FDA in 2022 - read more about the discovery, mechanisms of action, targets, and differentiation on all of them and download the hi-res poster here: drughunters.com/3GqtJMZ

📢 Are you a Scientist, Researcher, or Tech professional trained in #Barcelona and currently based abroad? 👩‍🔬👨‍🚀 Don't miss this #BarcelonaAlumni Global Summit, the annual meeting of Barcelona's global talent diaspora! 🗓️ Dec 22nd 📌 Barcelona 🎟️ Apply Now for a Free Invitation!

The ONA team is looking for a dynamic executive assistant! Join us! #Assistant #biotech #job

No és oklahoma, sinó Barcelona! Així ha arribat l’espectacular tempesta amb un arcus de llibre ⛈ IMPRESSIONANT… #Projecte4Estacions

NEWS | @AsabysPartners launches a new €200m fund to invest in #biotech & #healthtech, with commitments from @BancoSabadell and @AlantraGlobal 👉 ow.ly/mLzb50KLcyK #vc #investment #health #innovation

“We always aim high” you rock @valerievh001 @PCB_UB @OnaTherapeutics @diariARA @estherveraARA @SitAtTheTable @AsocEyC @WeRock_Capital

Ahir vaig tenir l'honor de recollir, de mans de la Consellera Gemma Geis, el premi de comunicació científica al @BSC_CNS pel programa “Som investigadores”, una iniciativa per acostar la supercomputació als (i LES) més joves… Petit 🧵 sobre el tema i les vocacions STEM

Congrats to @OnaTherapeutics for receiving the Innovation award in the creation of a scientific company 👏🏻 by @fundaciorecerca and sponsors @BoehringerES @bbva. #portfolio #biotech #innovation #premisRecerca #PNR22

🧵1/ We’re delighted to share “The Making of” MCLA-158, a therapeutic bispecific antibody targeting EGFR in LGR5 positive cancer stem cells, just published in @NatureCancer. #MCLA-158 #petosemtamab #Cancer  ➡️rdcu.be/cL4xS

🌙 See you tonight at the #CataloniaBioHT Gala! #NitCataloniaBioHT The networking event is expecting +250 entrepreneurs, executives, investors, institutional representatives, and stakeholders in the #health and #lifesciences sector in Catalonia 👉ow.ly/p6rp50Ip17R

Highly recommended. The story of a visionary oncologist who changed cancer care and our way of understanding medicine and research on this disease #CancersFiercestOpponent @AstraZeneca

🟢 Launching the 2022 edition of the #Biosuccess Award! 🏅The initiative recognises the best business milestone of 2021 in the health and life sciences sector in Catalonia You can submit candidacies until 28 February 👉 ow.ly/8cYR50HUzHY #WeAreCataloniaBioHT #BioExit

#Enfilall 👇| Fa poc ha sorgit una polèmica sobre la probable eutanàsia de 38 gossos Beagle utilitzats en investigació. Cal separar les males pràctiques (dutes a terme en aquest cas) de la necessitat de l’experimentació animal per investigar i trobar nous tractaments.⏬1/25

Looking for great people to join the ONA team!

Estem buscant un/a #emprenedor/a, idealment amb formació mixta #Biomedicina i #Empresa #MBA, per portar futura #startup spin-off derivada del nostre laboratori. Llença’t a aquesta aventura d’innovació i transferència tecnològica! Enviar sol·licitud aquí: carrerasresearch.org/en/intrapreneu…

I am thrilled to welcome Dr Michel Detheux as Independent Chair of ONA’s board of directors.

#portfolionews | @OnaTherapeutics appoints Dr Michel Detheux $ITOS as Independent Chair to the Board of Directors 🎯Developing #therapeutic biologics targeting #lipid metabolism to treat #advanced #cancer ▶ Full details here👉bit.ly/DrDetheux #oncology #innovation #vc

Congratulations to @OnaTherapeutics for the #Bioexit prize, a recognition for its growth as a spin-off! #WeAreCataloniaBioHT

Largest Spanish biotech acquisition to date: Vifor Pharma acquires Sanifit for €205 upfront + development and commercial milestones. Congratulations @SanifitLabs!! viforpharma.com/vifor-pharma-s…